National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 317981

Case Details

VAERS ID: 317981 (history)  
Form: Version 1.0  
Age: 14.0  
Gender: Female  
Location: Foreign  
   Days after vaccination:79
Submitted: 2008-06-30
   Days after onset:26
Entered: 2008-07-01
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Unknown       Purchased by: Unknown
Symptoms: Disorientation, Drug screen, Electroencephalogram normal, Gait disturbance, Nervous system disorder, Personality change, Sensorimotor disorder, Somnolence
SMQs:, Peripheral neuropathy (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (narrow), Dementia (broad), Parkinson-like events (broad), Drug abuse and dependence (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hostility/aggression (broad), Hypoglycaemia (broad), Dehydration (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 0 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Pollen allergy
Preexisting Conditions:
Diagnostic Lab Data: Electroencephalography, normal; Blood drug screen, 0.7 mg lorazepam; Urine drug screen, 0.7 mg lorazepam.
CDC Split Type: WAES0806USA08420

Write-up: Information has been received from a paediatrician concerning a 14 year old female patient with a history of pollen allergy who was vaccinated with the first dose of GARDASIL on 17-MAR-2008 (IM, upper arm). It was well tolerated). On 13-MAY-2008, the patient was vaccinated with the second dose of GARDASIL, lot # not provided, IM into the upper arm. On 04-JUN-2008, the patient developed neurological and sensorimotor disorders including disorientation, gait instability, personality change and somnolence. She was hospitalized and received lorazepam 0.7 mg. There were no inflammatory signs and EEG was normal. She recovered after 2 days. On 17-JUN-2008, the patient experienced a similar episode. The final outcome was unknown. Other business partner numbers included: E2008-05763. No further information is available.

New Search

Link To This Search Result:

Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166